High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.7M
$2,724,497
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2026-03-16 | $247,099 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2026-03-16 | $578,333 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2026-03-16 | $34,387 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
LINK WILLIAM J PHD
• Director
10b5-1 SellΔOwn -54.4%
2025-12-15
$458,433
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Director
10b5-1 SellΔOwn -54.4%
|
2025-12-15 | $458,433 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-12-15 | $407,717 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-12-15 | $388,429 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-12-15 | $515,516 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-12-15 | $94,584 | S | Form 4 |